Journal article
Transiently boosting Vγ9 Vδ2 γδ T cells early in Mtb coinfection of SIV-infected juvenile macaques does not improve Mtb host resistance
EC Larson, AL Ellis, MA Rodgers, AK Gubernat, JL Gleim, RV Moriarty, AJ Balgeman, YT de Menezes, CL Ameel, DJ Fillmore, SM Pergalske, JA Juno, P Maiello, HB Chishti, PL Lin, DI Godfrey, SJ Kent, DG Pellicci, LC Ndhlovu, SL O'Connor Show all
Infection and Immunity | Published : 2024
DOI: 10.1128/iai.00313-24
Abstract
Children living with HIV have a higher risk of developing tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb). Gamma delta (γδ) T cells in the context of HIV/Mtb coinfection have been understudied in children despite in vitro evidence suggesting γδ T cells assist with Mtb control. We investigated whether boosting a specific subset of γδ T cells, phosphoantigen-reactive Vγ9+Vδ2+ cells, could improve TB outcome using a nonhuman primate model of pediatric HIV/Mtb coinfection. Juvenile Mauritian cynomolgus macaques (MCM), equivalent to 4- to 8-year-old children, were infected intravenously (i.v.) with SIV. After 6 months, MCM were coinfected with a low dose of M..
View full abstractRelated Projects (2)
Grants
Awarded by AbbVie
Funding Acknowledgements
We thank the incredible veterinary and laboratory staffs of the TB Research Group at the University of Pittsburgh for their contribution to this study. We are grateful to Dr. Edwin Klein, DVM, for his expert review of the histopathology slides. E.C.L. was supported by National Institute of Health (NIH) K01 award OD033539.